Tenpoint Therapeutics has announced positive topline results from BRIO-II, its second Phase 3 pivota...

Lenz Therapeutics announced positive topline results from its Phase 3 CLARITY study, evaluating two ...

VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovati...

Researchers at Boston Children's Hospital have made a significant advancement in understanding the g...

ENTOD Pharmaceuticals, a Mumbai-based company, has achieved a significant milestone in eye care with...

Vision therapy is a specialized form of optometric care that utilizes a series of customized visual ...

Opus Genetics has completed enrollment in the VEGA-3 Phase 3 clinical trial evaluating phentolamine ...

Alsanza GmbH, a company known for its innovative ophthalmic products, continues to draw attention to...

Orasis Pharmaceuticals has announced the U.S. availability of its novel corrective eye drop, Qlosi (...

Tenpoint Therapeutics, a clinical-stage biotechnology company, has announced the submission of a New...